GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Brasil Pharma SA (BSP:BPHA3) » Definitions » LT-Debt-to-Total-Asset

Brasil Pharma (BSP:BPHA3) LT-Debt-to-Total-Asset : 0.85 (As of Mar. 2019)


View and export this data going back to 2011. Start your Free Trial

What is Brasil Pharma LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Brasil Pharma's long-term debt to total assests ratio for the quarter that ended in Mar. 2019 was 0.85.

Brasil Pharma's long-term debt to total assets ratio increased from Mar. 2018 (0.00) to Mar. 2019 (0.85). It may suggest that Brasil Pharma is progressively becoming more dependent on debt to grow their business.


Brasil Pharma LT-Debt-to-Total-Asset Historical Data

The historical data trend for Brasil Pharma's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brasil Pharma LT-Debt-to-Total-Asset Chart

Brasil Pharma Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only 0.04 0.01 0.01 - 0.68

Brasil Pharma Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.68 0.85

Brasil Pharma LT-Debt-to-Total-Asset Calculation

Brasil Pharma's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2018 is calculated as

LT Debt to Total Assets (A: Dec. 2018 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2018 )/Total Assets (A: Dec. 2018 )
=48.825/72.15
=0.68

Brasil Pharma's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2019 is calculated as

LT Debt to Total Assets (Q: Mar. 2019 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2019 )/Total Assets (Q: Mar. 2019 )
=59.922/70.49
=0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brasil Pharma  (BSP:BPHA3) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Brasil Pharma LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Brasil Pharma's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Brasil Pharma (BSP:BPHA3) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Presidente Juscelino Kubitschek, 1,830, 3rd floor, Itaim Bibi, Sao Paulo, SP, BRA, 04543-900
Brasil Pharma SA is a Brazil-based company primarily engaged in the pharmaceutical retail sector. The company operates in the retail sale of medicines, perfumes, cosmetics, skincare and beauty products and toiletries. The operating segments of the company are Retail sector and Service sector, of which majority of the revenue is generated from the Retail segment. The group has its presence in all the regions of Brazil through its own stores and a franchise network. The owned stores of the company are operated under the Big Ben, Guararapes, District Pharmacy Rosary, Sant'Ana and Mais Economica brands. The company's franchises operate under the Farmais brand.

Brasil Pharma (BSP:BPHA3) Headlines

No Headlines